Innoviva director granted stock and options awards
Innoviva, Inc. director Linden Josephine reported equity compensation awards tied to their appointment to the Board on May 18, 2026.
Rhea-AI Filing Summary
Innoviva, Inc. director Linden Josephine reported equity compensation awards tied to their appointment to the Board on May 18, 2026. They received 9,461 shares of common stock and a separate 5,733-share restricted stock unit grant, all at no cash cost. In addition, they were granted non-statutory stock options for 9,166 shares of common stock at an exercise price of $21.80 per share, expiring in 2036. The RSUs vest over two years, while the options and additional RSUs vest at the earlier of the next annual stockholder meeting or one year after the grant date, subject to continued service and certain acceleration events.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 24,360 shares
Grant/Award
3 txns
Insider
Linden Josephine
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-statutory Stock Option | 9,166 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,733 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 9,461 | $0.00 | $0.00 |
Holdings After Transaction:
Non-statutory Stock Option — 9,166 contracts (Direct);
Common Stock — 15,194 shares (Direct)
Footnotes (3)
- F1. The Reporting Person was granted restricted stock units ("RSUs") and non-statutory stock options ("Options") upon their appointment to the Issuer's Board of Directors ("Board") on May 18, 2026 (the "Effective Date").
- F2. The RSUs vest in equal installments on each of the first two anniversaries of the Effective Date.
- F3. Options and additional RSUs were granted and will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of the Effective Date, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date, with accelerated vesting upon the Reporting Person's death, disability, or in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan), provided that the Reporting Person has not experienced a termination prior to such "change in control," death or disability.
Key Figures
Common stock grant: 9,461 shares
Additional RSU grant: 5,733 shares
Stock options granted: 9,166 options
+5 more
8 metrics
Common stock grant
9,461 shares
Common stock awarded at $0.00 per share on May 18, 2026
Additional RSU grant
5,733 shares
Restricted stock units awarded on May 18, 2026
Stock options granted
9,166 options
Non-statutory stock options granted on May 18, 2026
Option exercise price
$21.80 per share
Exercise price for non-statutory stock options
Options expiration
May 17, 2036
Expiration date of non-statutory stock options
Shares held after grant
15,194 shares
Total common shares following the 9,461-share award
RSU holding after grant
5,733 units
Total RSUs following the 5,733-unit award entry
Options held after grant
9,166 options
Total non-statutory options following the grant
Key Terms
restricted stock units ("RSUs"), non-statutory stock options, Outside Director, change in control, +1 more
5 terms
restricted stock units ("RSUs") financial
"The Reporting Person was granted restricted stock units ("RSUs") and non-statutory stock options"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
non-statutory stock options financial
"granted restricted stock units ("RSUs") and non-statutory stock options ("Options") upon their appointment"
Non-statutory stock options are a type of reward that companies give to employees, allowing them to buy company shares at a set price within a certain period. Unlike formal or government-approved plans, these options are more flexible but may have different tax implications. For investors, they can influence a company's stock price and financial health, making them an important factor to consider.
Outside Director financial
"subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date"
change in control financial
"in the event of a "change in control" (as defined in the Issuer's 2026 Equity Incentive Plan)"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
2026 Equity Incentive Plan financial
"as defined in the Issuer's 2026 Equity Incentive Plan), provided that the Reporting Person"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Linden Josephine receive from Innoviva (INVA)?
Linden Josephine received equity compensation as a director, including 9,461 shares of common stock, 5,733 additional restricted stock units, and non-statutory stock options for 9,166 shares at a $21.80 exercise price. These awards reflect standard Board-related compensation, not open-market purchases.
When do Linden Josephine’s Innoviva (INVA) RSUs vest?
One Innoviva RSU grant vests in equal installments on each of the first two anniversaries of May 18, 2026. Additional RSUs vest at the earlier of the next annual stockholder meeting or one year after that date, assuming continued service as an Outside Director.
What are the terms of Linden Josephine’s Innoviva (INVA) stock options?
Linden Josephine was granted non-statutory stock options for 9,166 Innoviva shares at a $21.80 exercise price. These options are scheduled to vest at the earlier of the next annual stockholder meeting or one year after May 18, 2026, and expire on May 17, 2036.
What triggers accelerated vesting of Innoviva (INVA) awards for Linden Josephine?
The awards provide for accelerated vesting upon Linden Josephine’s death, disability, or certain change in control events defined in Innoviva’s 2026 Equity Incentive Plan, so long as they have not experienced a termination before the applicable change in control, death, or disability event.
AI-generated analysis. How Rhea-AI works. Not financial advice.
